Successful treatment of in‐transit melanoma metastases using topical 2‐4 dinitrochlorobenzene
- 12 November 2003
- journal article
- case report
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 44 (4) , 277-280
- https://doi.org/10.1046/j.1440-0960.2003.00009.x
Abstract
A 78‐year‐old woman presented with multiple histologically proven in‐transit melanoma metastases involving the lower half of the left leg. Initial therapy with liquid nitrogen cryotherapy had some short‐lived success but was not tolerated by the patient. As further lesions began to develop, daily topical application of 2% 2‐4 dinitrochlorobenzene to the lesions was commenced. During the first 2 years of therapy a partial response was achieved, with treated lesions regressing while new lesions developed. Eventually a long‐term remission of almost 2 years with no clinical evidence of cutaneous melanoma deposits was achieved. This treatment did not prevent metastatic lymph node and ultimately fatal liver involvement. Topical immunotherapy can be a useful adjunct in the treatment of cutaneous melanoma metastases, particularly in those patients who are unable to tolerate other destructive modalities of therapy.Keywords
This publication has 10 references indexed in Scilit:
- U.K. guidelines for the management of cutaneous melanomaBritish Journal of Dermatology, 2002
- Factors Associated With Response to High-Dose Interleukin-2 in Patients With Metastatic MelanomaJournal of Clinical Oncology, 2001
- Electrochemotherapy of cutaneous metastases in malignant melanomaMelanoma Research, 2000
- Evaluation of Vaccinia Viral Lysates as Therapeutic Vaccines in the Treatment of MelanomaaAnnals of the New York Academy of Sciences, 1993
- DNCB reactivity and prognosis in 419 patients with malignant melanomaCancer, 1981
- Intralesional treatment of recurrent metastatic cutaneous malignant melanoma.A randomized prospective study of intralesional bacillus calmette-guerin versus intralesional dinitrochlorobenzeneCancer, 1978
- REMISSION OF MELANOMA WITH D.N.C.B. TREATMFNTThe Lancet, 1973
- Immunotherapy of malignant melanoma. A clinical trialCancer, 1973
- A Method for Dinitrochlorobenzene Contact SensitizationNew England Journal of Medicine, 1972
- Delayed hypersensitive reactions: A growing class of immunologic phenomenaJournal of Allergy, 1960